Cell Culture

Cell Culture

The cell culture market is expected to register a CAGR of approx. 11% over the period of 2022-2030. The cell culture market refers to the industry involved in the production, maintenance, and utilization of living cells, tissues, or organs in an artificial environment. Cell culture involves the growth and multiplication of cells outside their natural environment, typically in a laboratory setting. These cultured cells are used in various research, biopharmaceutical, and biotechnology applications. Cell culture is a fundamental technique in biomedical research, allowing scientists to study the behavior, characteristics, and functions of cells in a controlled environment. It plays a crucial role in the development of new drugs, vaccines, and therapies, as well as in understanding the mechanisms of diseases and discovering potential treatments. The growing demand for cell culture can be attributed to the rise in the number of cancer research projects and the broadening scope of applications for gene therapies are the key factors that boost the adoption of inorganic growth strategies among key industry players around the globe. For instance, in January 2022, Cytiva (Danaher Corporation) collaborated with Nucleus Biologics for the development of custom culture media for cell and gene therapies. Owing to the glaring statistics cell culture is being used for a variety of applications across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the cell culture market is anticipated to grow on account of the demand for biopharmaceuticals, such as monoclonal antibodies, vaccines, and recombinant proteins, is increasing. However, some of the restraints in the market including the contamination risks and complex scale-up processes are impeding the growth of this market all over the world.

• Based on consumables, the market is segmented into media, sera, and reagents. Among them, the media segment captured a significant share of the market in 2021. the rising demand for media items used in research and development. The emergence of serum- and animal-component-free and tailored media alternatives has expanded media product market penetration. Furthermore, specialized media for stem cell applications are becoming more market, which is projected to drive the segment's expansion.
• Based on the product, the market is bifurcated into culture systems, incubators, centrifuges, cryostorage equipment, biosafety equipment, and pipetting instruments. Among them, the culture systems segment is expected to grow at a higher CAGR in the market. Three-dimensional (3D) cell culture systems better mimic the in vivo cellular environment compared to traditional two-dimensional (2D) systems. 3D culture systems allow cells to interact more closely, form complex tissue-like structures, and exhibit more physiologically relevant behavior. The increasing demand for more accurate and predictive cell culture models has led to the adoption of 3D culture systems, boosting the market for these technologies.
• Based on the application, the cell culture market has been classified into biopharmaceuticals, tissue culture & engineering, vaccine production, drug development, gene therapy, toxicity testing, cancer research, and others. Among them, the biopharmaceuticals category grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period because mammalian cell lines, such as the Chinese hamster ovary, are used in the production of biopharmaceuticals, and there is a growing need for non-conventional medications, biopharmaceutical uses of cell culture techniques are predicted to rise. Furthermore, the recent discovery of numerous grafting procedures and tailored therapy alternatives has broadened the biopharmaceutical domain's potential prospects.
• For a better understanding of the market adoption of cell culture, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. Cell culture have gained increasing popularity in North America due to various factors. North America has a robust biopharmaceutical industry with numerous biotech and pharmaceutical companies conducting research and development activities. The demand for cell culture products and services is driven by the region's focus on drug discovery, biologics production, and advancements in precision medicine. For instance, in March 2021, Thermo Fisher Scientific, a leading provider of cell culture products, announced the expansion of its bioproduction capabilities in North America with the opening of a new bioprocessing collaboration center in St. Louis, Missouri. The facility aims to support the development and manufacturing of cell and gene therapies, strengthening the cell culture ecosystem in the region. North America is at the forefront of technological advancements in cell culture, including the development of advanced culture systems, automation, and bioprocessing technologies. The region's strong focus on innovation drives the adoption of cutting-edge cell culture techniques and products. Moreover, North America is home to renowned research institutions, universities, and academic centers that conduct extensive cell culture research. The presence of these institutions fosters collaborations, knowledge exchange, and the advancement of cell culture techniques and applications.
• Some of the major players operating in Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Hi Media Laboratories Pvt. Ltd., Merck KGaA, Corning Incorporated, Sartorius AG, Fujifilm Holdings Corporation, Lonza Group Ltd, Caisson Laboratories Inc among others. Several M&A’s along with partnerships have been undertaken.